- Home
- GCMG vs MGTX Comparison
GCMG vs MGTX Comparison
Compare GCMG & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCMG
- MGTX
- Stock Information
- Founded
- GCMG 1971
- MGTX 2015
- Country
- GCMG United States
- MGTX United States
- Employees
- GCMG N/A
- MGTX N/A
- Industry
- GCMG Finance/Investors Services
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GCMG Finance
- MGTX Health Care
- Exchange
- GCMG Nasdaq
- MGTX Nasdaq
- Market Cap
- GCMG 631.4M
- MGTX 520.8M
- IPO Year
- GCMG N/A
- MGTX N/A
- Fundamental
- Price
- GCMG $11.51
- MGTX $6.54
- Analyst Decision
- GCMG Hold
- MGTX Strong Buy
- Analyst Count
- GCMG 5
- MGTX 2
- Target Price
- GCMG $13.60
- MGTX $24.00
- AVG Volume (30 Days)
- GCMG 484.4K
- MGTX 400.2K
- Earning Date
- GCMG 08-07-2025
- MGTX 08-11-2025
- Dividend Yield
- GCMG 3.83%
- MGTX N/A
- EPS Growth
- GCMG N/A
- MGTX N/A
- EPS
- GCMG 0.14
- MGTX N/A
- Revenue
- GCMG $530,455,000.00
- MGTX $34,508,000.00
- Revenue This Year
- GCMG $2.72
- MGTX $365.04
- Revenue Next Year
- GCMG $12.99
- MGTX $73.18
- P/E Ratio
- GCMG $84.60
- MGTX N/A
- Revenue Growth
- GCMG 17.38
- MGTX 203.23
- 52 Week Low
- GCMG $9.56
- MGTX $3.85
- 52 Week High
- GCMG $14.48
- MGTX $8.75
- Technical
- Relative Strength Index (RSI)
- GCMG 28.67
- MGTX 59.03
- Support Level
- GCMG $11.37
- MGTX $6.07
- Resistance Level
- GCMG $11.95
- MGTX $6.60
- Average True Range (ATR)
- GCMG 0.28
- MGTX 0.41
- MACD
- GCMG -0.08
- MGTX 0.03
- Stochastic Oscillator
- GCMG 10.29
- MGTX 71.90
About GCMG GCM Grosvenor Inc.
GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. Company invest maximum in Private Equity. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.